Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 22Prostatic Neoplasms 11Osteoporosis 8Vitamin D Deficiency 7Polycystic Ovary Syndrome 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Colonic Neoplasms 5Obesity 3Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Inflammation 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Bone Diseases, Metabolic 3Multiple Endocrine Neoplasia Type 1 2Motor Activity 2Lymphoma 2Leukemia 2Leiomyoma 2Giant Cell Tumor of Bone 2Gastrointestinal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Bone Diseases 2Warts 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 679130-nm albumin-bound paclitaxel 198Fluorouracil 186Oxaliplatin 175Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 131Irinotecan 113Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 72Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 49Magnetic Resonance Spectroscopy 46folfirinox 42Docetaxel 41Cetuximab 40Specimen Handling 37irinotecan sucrosofate 36S 1 (combination) 36Biopsy 31Radiation 29Paclitaxel 29Ipilimumab 27durvalumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Vitamin D × Clear all
NCT03883919 2022-10-05

Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy

Washington University School of Medicine

Phase 1 Completed
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡